ID 5HT1E_HUMAN Reviewed; 365 AA. AC P28566; E1P503; Q9P1Y1; DT 01-DEC-1992, integrated into UniProtKB/Swiss-Prot. DT 01-DEC-1992, sequence version 1. DT 24-JUL-2024, entry version 207. DE RecName: Full=5-hydroxytryptamine receptor 1E; DE Short=5-HT-1E; DE Short=5-HT1E; DE AltName: Full=S31; DE AltName: Full=Serotonin receptor 1E; GN Name=HTR1E; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION. RC TISSUE=Brain; RX PubMed=1608964; DOI=10.1073/pnas.89.12.5517; RA McAllister G., Charlesworth A., Snodin C., Beer M.S., Noble A.J., RA Middlemiss D.N., Iversen L.L., Whiting P.; RT "Molecular cloning of a serotonin receptor from human brain (5HT1E): a RT fifth 5HT1-like subtype."; RL Proc. Natl. Acad. Sci. U.S.A. 89:5517-5521(1992). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=1733778; DOI=10.1016/0014-5793(92)80379-u; RA Levy F.O., Gudermann T., Birnbaumer M., Kaumann A.J., Birnbaumer L.; RT "Molecular cloning of a human gene (S31) encoding a novel serotonin RT receptor mediating inhibition of adenylyl cyclase."; RL FEBS Lett. 296:201-206(1992). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=1513320; RA Zgombick J.M., Schechter L.E., Macchi M., Hartig P.R., Branchek T.A., RA Weinshank R.L.; RT "Human gene S31 encodes the pharmacologically defined serotonin 5- RT hydroxytryptamine1E receptor."; RL Mol. Pharmacol. 42:180-185(1992). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RA Puhl H.L. III, Ikeda S.R., Aronstam R.S.; RT "cDNA clones of human proteins involved in signal transduction sequenced by RT the Guthrie cDNA resource center (www.cdna.org)."; RL Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=14574404; DOI=10.1038/nature02055; RA Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., RA Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., RA Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., RA Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., RA Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H., RA Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J., RA Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., RA Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., RA Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., RA Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E., RA Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J., RA French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J., RA Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C., RA Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A., RA Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R., RA Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., RA Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., RA Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., RA Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., RA Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A., RA Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L., RA Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I., RA Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y., RA Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E., RA Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A., RA Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W., RA Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., RA West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J., RA Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M., RA Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I., RA Rogers J., Beck S.; RT "The DNA sequence and analysis of human chromosome 6."; RL Nature 425:805-811(2003). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [8] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-363. RX PubMed=15014171; DOI=10.1093/molbev/msh100; RA Kitano T., Liu Y.-H., Ueda S., Saitou N.; RT "Human-specific amino acid changes found in 103 protein-coding genes."; RL Mol. Biol. Evol. 21:936-944(2004). RN [9] RP FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RX PubMed=14744596; DOI=10.1016/j.ejphar.2003.11.019; RA Bai F., Yin T., Johnstone E.M., Su C., Varga G., Little S.P., Nelson D.L.; RT "Molecular cloning and pharmacological characterization of the guinea pig RT 5-HT1E receptor."; RL Eur. J. Pharmacol. 484:127-139(2004). RN [10] RP REVIEW. RX PubMed=18476671; DOI=10.1021/cr078224o; RA Nichols D.E., Nichols C.D.; RT "Serotonin receptors."; RL Chem. Rev. 108:1614-1641(2008). RN [11] RP FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=21422162; DOI=10.1124/jpet.111.179606; RA Klein M.T., Dukat M., Glennon R.A., Teitler M.; RT "Toward selective drug development for the human 5-hydroxytryptamine 1E RT receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure- RT affinity relationships."; RL J. Pharmacol. Exp. Ther. 337:860-867(2011). RN [12] RP REVIEW. RX PubMed=20945968; DOI=10.33549/physiolres.931903; RA Pytliak M., Vargova V., Mechirova V., Felsoci M.; RT "Serotonin receptors - from molecular biology to clinical applications."; RL Physiol. Res. 60:15-25(2011). RN [13] RP VARIANT PHE-262. RX PubMed=10391209; DOI=10.1038/10290; RA Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., RA Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., RA Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., RA Lander E.S.; RT "Characterization of single-nucleotide polymorphisms in coding regions of RT human genes."; RL Nat. Genet. 22:231-238(1999). RN [14] RP ERRATUM OF PUBMED:10391209. RA Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., RA Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., RA Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., RA Lander E.S.; RL Nat. Genet. 23:373-373(1999). CC -!- FUNCTION: G-protein coupled receptor for 5-hydroxytryptamine CC (serotonin). Also functions as a receptor for various alkaloids and CC psychoactive substances. Ligand binding causes a conformation change CC that triggers signaling via guanine nucleotide-binding proteins (G CC proteins) and modulates the activity of down-stream effectors, such as CC adenylate cyclase. Signaling inhibits adenylate cyclase activity. CC {ECO:0000269|PubMed:14744596, ECO:0000269|PubMed:1513320, CC ECO:0000269|PubMed:1608964, ECO:0000269|PubMed:1733778, CC ECO:0000269|PubMed:21422162}. CC -!- INTERACTION: CC P28566; P50222: MEOX2; NbExp=3; IntAct=EBI-1043151, EBI-748397; CC P28566; Q96CV9: OPTN; NbExp=3; IntAct=EBI-1043151, EBI-748974; CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14744596, CC ECO:0000269|PubMed:1513320, ECO:0000269|PubMed:1608964, CC ECO:0000269|PubMed:1733778, ECO:0000269|PubMed:21422162}; Multi-pass CC membrane protein {ECO:0000269|PubMed:14744596, CC ECO:0000269|PubMed:1513320, ECO:0000269|PubMed:1608964, CC ECO:0000269|PubMed:1733778, ECO:0000269|PubMed:21422162}. CC -!- TISSUE SPECIFICITY: Detected in brain. {ECO:0000269|PubMed:14744596}. CC -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family. CC {ECO:0000255|PROSITE-ProRule:PRU00521}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M91467; AAA58353.1; -; mRNA. DR EMBL; Z11166; CAA77558.1; -; Genomic_DNA. DR EMBL; M92826; AAA58355.1; -; Genomic_DNA. DR EMBL; AF498980; AAM21127.1; -; mRNA. DR EMBL; AL157777; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471051; EAW48616.1; -; Genomic_DNA. DR EMBL; CH471051; EAW48617.1; -; Genomic_DNA. DR EMBL; BC069751; AAH69751.1; -; mRNA. DR EMBL; AB041373; BAA94458.1; -; Genomic_DNA. DR CCDS; CCDS5006.1; -. DR PIR; S20579; A45260. DR RefSeq; NP_000856.1; NM_000865.2. DR RefSeq; XP_011534091.1; XM_011535789.2. DR PDB; 7E33; EM; 2.90 A; R=2-365. DR PDBsum; 7E33; -. DR AlphaFoldDB; P28566; -. DR SMR; P28566; -. DR BioGRID; 109586; 8. DR IntAct; P28566; 7. DR STRING; 9606.ENSP00000307766; -. DR BindingDB; P28566; -. DR ChEMBL; CHEMBL2182; -. DR DrugBank; DB01238; Aripiprazole. DR DrugBank; DB14185; Aripiprazole lauroxil. DR DrugBank; DB01239; Chlorprothixene. DR DrugBank; DB00363; Clozapine. DR DrugBank; DB11273; Dihydroergocornine. DR DrugBank; DB13345; Dihydroergocristine. DR DrugBank; DB00320; Dihydroergotamine. DR DrugBank; DB01049; Ergoloid mesylate. DR DrugBank; DB12141; Gilteritinib. DR DrugBank; DB01221; Ketamine. DR DrugBank; DB12540; Lecozotan. DR DrugBank; DB00408; Loxapine. DR DrugBank; DB00247; Methysergide. DR DrugBank; DB00334; Olanzapine. DR DrugBank; DB00715; Paroxetine. DR DrugBank; DB01224; Quetiapine. DR DrugBank; DB00953; Rizatriptan. DR DrugBank; DB09304; Setiptiline. DR DrugBank; DB13025; Tiapride. DR DrugBank; DB00246; Ziprasidone. DR DrugBank; DB00315; Zolmitriptan. DR DrugCentral; P28566; -. DR GuidetoPHARMACOLOGY; 4; -. DR GlyCosmos; P28566; 2 sites, No reported glycans. DR GlyGen; P28566; 2 sites. DR iPTMnet; P28566; -. DR PhosphoSitePlus; P28566; -. DR BioMuta; HTR1E; -. DR DMDM; 112822; -. DR PaxDb; 9606-ENSP00000307766; -. DR PeptideAtlas; P28566; -. DR Antibodypedia; 1480; 199 antibodies from 31 providers. DR DNASU; 3354; -. DR Ensembl; ENST00000305344.7; ENSP00000307766.4; ENSG00000168830.8. DR GeneID; 3354; -. DR KEGG; hsa:3354; -. DR MANE-Select; ENST00000305344.7; ENSP00000307766.4; NM_000865.3; NP_000856.1. DR UCSC; uc003pli.4; human. DR AGR; HGNC:5291; -. DR CTD; 3354; -. DR DisGeNET; 3354; -. DR GeneCards; HTR1E; -. DR HGNC; HGNC:5291; HTR1E. DR HPA; ENSG00000168830; Tissue enhanced (brain, ovary). DR MIM; 182132; gene. DR neXtProt; NX_P28566; -. DR OpenTargets; ENSG00000168830; -. DR PharmGKB; PA29552; -. DR VEuPathDB; HostDB:ENSG00000168830; -. DR eggNOG; KOG3656; Eukaryota. DR GeneTree; ENSGT01010000222287; -. DR HOGENOM; CLU_009579_11_1_1; -. DR InParanoid; P28566; -. DR OMA; IHTSIRI; -. DR OrthoDB; 2999405at2759; -. DR PhylomeDB; P28566; -. DR TreeFam; TF316350; -. DR PathwayCommons; P28566; -. DR Reactome; R-HSA-390666; Serotonin receptors. DR Reactome; R-HSA-418594; G alpha (i) signalling events. DR SignaLink; P28566; -. DR SIGNOR; P28566; -. DR BioGRID-ORCS; 3354; 13 hits in 1145 CRISPR screens. DR ChiTaRS; HTR1E; human. DR GeneWiki; 5-HT1E_receptor; -. DR GenomeRNAi; 3354; -. DR Pharos; P28566; Tchem. DR PRO; PR:P28566; -. DR Proteomes; UP000005640; Chromosome 6. DR RNAct; P28566; Protein. DR Bgee; ENSG00000168830; Expressed in primordial germ cell in gonad and 53 other cell types or tissues. DR GO; GO:0030425; C:dendrite; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; IMP:UniProtKB. DR GO; GO:0045202; C:synapse; IEA:GOC. DR GO; GO:0004930; F:G protein-coupled receptor activity; TAS:ProtInc. DR GO; GO:0004993; F:G protein-coupled serotonin receptor activity; IDA:MGI. DR GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central. DR GO; GO:0051378; F:serotonin binding; IDA:MGI. DR GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; IMP:UniProtKB. DR GO; GO:0007198; P:adenylate cyclase-inhibiting serotonin receptor signaling pathway; IBA:GO_Central. DR GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central. DR GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:ProtInc. DR GO; GO:0007187; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; IBA:GO_Central. DR CDD; cd15335; 7tmA_5-HT1E; 1. DR Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1. DR InterPro; IPR002231; 5HT_rcpt. DR InterPro; IPR000276; GPCR_Rhodpsn. DR InterPro; IPR017452; GPCR_Rhodpsn_7TM. DR PANTHER; PTHR24247; 5-HYDROXYTRYPTAMINE RECEPTOR; 1. DR PANTHER; PTHR24247:SF33; 5-HYDROXYTRYPTAMINE RECEPTOR 1E; 1. DR Pfam; PF00001; 7tm_1; 1. DR PRINTS; PR01101; 5HTRECEPTOR. DR PRINTS; PR00237; GPCRRHODOPSN. DR SMART; SM01381; 7TM_GPCR_Srsx; 1. DR SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1. DR PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1. DR PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; Disulfide bond; G-protein coupled receptor; KW Glycoprotein; Membrane; Receptor; Reference proteome; Transducer; KW Transmembrane; Transmembrane helix. FT CHAIN 1..365 FT /note="5-hydroxytryptamine receptor 1E" FT /id="PRO_0000068933" FT TOPO_DOM 1..22 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 23..47 FT /note="Helical; Name=1" FT /evidence="ECO:0000250" FT TOPO_DOM 48..59 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 60..82 FT /note="Helical; Name=2" FT /evidence="ECO:0000250" FT TOPO_DOM 83..96 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 97..118 FT /note="Helical; Name=3" FT /evidence="ECO:0000250" FT TOPO_DOM 119..138 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 139..159 FT /note="Helical; Name=4" FT /evidence="ECO:0000250" FT TOPO_DOM 160..179 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 180..202 FT /note="Helical; Name=5" FT /evidence="ECO:0000250" FT TOPO_DOM 203..291 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 292..314 FT /note="Helical; Name=6" FT /evidence="ECO:0000250" FT TOPO_DOM 315..324 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 325..347 FT /note="Helical; Name=7" FT /evidence="ECO:0000250" FT TOPO_DOM 348..365 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT MOTIF 119..121 FT /note="DRY motif; important for ligand-induced conformation FT changes" FT /evidence="ECO:0000250" FT MOTIF 340..344 FT /note="NPxxY motif; important for ligand-induced FT conformation changes and signaling" FT /evidence="ECO:0000250" FT BINDING 102 FT /ligand="ergotamine" FT /ligand_id="ChEBI:CHEBI:190463" FT /ligand_note="agonist" FT /evidence="ECO:0000250|UniProtKB:P28222" FT BINDING 107 FT /ligand="ergotamine" FT /ligand_id="ChEBI:CHEBI:190463" FT /ligand_note="agonist" FT /evidence="ECO:0000250|UniProtKB:P28222" FT BINDING 175 FT /ligand="ergotamine" FT /ligand_id="ChEBI:CHEBI:190463" FT /ligand_note="agonist" FT /evidence="ECO:0000250|UniProtKB:P28222" FT CARBOHYD 2 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 5 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 95..173 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00521" FT VARIANT 208 FT /note="A -> T (in dbSNP:rs3828741)" FT /id="VAR_022061" FT VARIANT 262 FT /note="S -> F (in dbSNP:rs6303)" FT /evidence="ECO:0000269|PubMed:10391209" FT /id="VAR_014165" FT HELIX 21..49 FT /evidence="ECO:0007829|PDB:7E33" FT HELIX 51..53 FT /evidence="ECO:0007829|PDB:7E33" FT HELIX 56..74 FT /evidence="ECO:0007829|PDB:7E33" FT HELIX 76..84 FT /evidence="ECO:0007829|PDB:7E33" FT HELIX 94..125 FT /evidence="ECO:0007829|PDB:7E33" FT HELIX 129..133 FT /evidence="ECO:0007829|PDB:7E33" FT HELIX 136..154 FT /evidence="ECO:0007829|PDB:7E33" FT TURN 155..157 FT /evidence="ECO:0007829|PDB:7E33" FT HELIX 180..190 FT /evidence="ECO:0007829|PDB:7E33" FT HELIX 192..211 FT /evidence="ECO:0007829|PDB:7E33" FT HELIX 284..315 FT /evidence="ECO:0007829|PDB:7E33" FT HELIX 323..345 FT /evidence="ECO:0007829|PDB:7E33" FT HELIX 349..357 FT /evidence="ECO:0007829|PDB:7E33" SQ SEQUENCE 365 AA; 41682 MW; 4C31DD783A3F7483 CRC64; MNITNCTTEA SMAIRPKTIT EKMLICMTLV VITTLTTLLN LAVIMAIGTT KKLHQPANYL ICSLAVTDLL VAVLVMPLSI IYIVMDRWKL GYFLCEVWLS VDMTCCTCSI LHLCVIALDR YWAITNAIEY ARKRTAKRAA LMILTVWTIS IFISMPPLFW RSHRRLSPPP SQCTIQHDHV IYTIYSTLGA FYIPLTLILI LYYRIYHAAK SLYQKRGSSR HLSNRSTDSQ NSFASCKLTQ TFCVSDFSTS DPTTEFEKFH ASIRIPPFDN DLDHPGERQQ ISSTRERKAA RILGLILGAF ILSWLPFFIK ELIVGLSIYT VSSEVADFLT WLGYVNSLIN PLLYTSFNED FKLAFKKLIR CREHT //